THE UPTAKE AND METABOLISM OF CYCLOPHOSPHAMIDE BY THE OVARY

被引:11
作者
ATAYA, K
PYDYN, E
YOUNG, J
STRUCK, R
机构
[1] CASE WESTERN RESERVE UNIV,DEPT REPROD BIOL,CLEVELAND,OH 44106
[2] SO RES INST,BIRMINGHAM,AL 35255
来源
SELECTIVE CANCER THERAPEUTICS | 1990年 / 6卷 / 02期
关键词
D O I
10.1089/sct.1990.6.83
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The uptake of cyclophosphamide (CTX) and its metabolites was evaluated by injecting adult femal rats with 14C-CTX on the morning of metestrous or proestrus. Rats were sacrificed 1 and 5 hours after 14C-CTX injection. The ovary, uterus, spleen, thymus, liver, kidney, anterior pituitary, duodenum, skeletal muscle and whole blood were isolated from each rat. Samples were combusted using a biological material oxidizer and the resulting CO2 was absorbed and counted. Liver and kidney had the highest uptake of 14C-radio-activity. The ovary appears to have 14C uptake comparable to the thymus and other tissues. Metabolism of CTX by the ovary was investigated by incubating 14C-CTX with human and rat granulosa cells and other ovarian cells obtained from pregnant mares‘ serum gonadotropin (PMSG)-primed immature rats, in separate experiments. The conversion of CTX to two marker metabolites, 4-ketocyclo-phosphamide and 4-hydroxycyclophosphamide was negligible and did not change in the presence of luteinizing hormone (LH). It is concluded that 1) following 14C-CTX injection, the ovary takes up a proportion of 14C-radioactivity comparable to other target tissues (e.g. thymus) and 2) the ovary is not capable of activating CTX in vitro in our system. © 1990, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 30 条
  • [1] EFFECT OF PHENOBARBITAL ON PLASMA-LEVELS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN MOUSE
    ALBERTS, DS
    PENG, YM
    CHEN, HS
    STRUCK, RF
    [J]. BRITISH JOURNAL OF CANCER, 1978, 38 (02) : 316 - 324
  • [2] Ataya K M, 1988, Reprod Toxicol, V2, P105, DOI 10.1016/0890-6238(88)90005-6
  • [3] ATAYA KM, 1985, CANCER RES, V45, P3651
  • [4] ATAYA KM, 1989, CANCER RES, V49, P1660
  • [5] BURKL W, 1978, CELL TISSUE RES, V186, P351
  • [6] Calabreis P, 1980, PHARMACOL BASIS THER, P1256
  • [8] Chandramouli K, 1969, Indian J Cancer, V6, P153
  • [9] COLVIN M, 1981, CANCER TREAT REP, V65, P89
  • [10] CROOK T, 1986, CANCER RES, V469, P5029